Table 3.
Linear Regression Analysis for the Association of NAFLD with Continuous Markers of Subclinical Myocardial Dysfunction, The CARDIA Study, 2010-2011
Model 1: Base modela | Model 2: Base + HF risk factorsb | Model 3: Base + BMI | Model 4: Base + VAT | Model 5: Base + HF risk factors + BMI | Model 6: Base + HF risk factors + VAT | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
β (SE) | P value | β (SE) | P value | β (SE) | P value | β (SE) | P value | β (SE) | P value | β (SE) | P value | |
Cardiac Dimensions | ||||||||||||
LV mass indexc | 5.8 (0.8) | <0.0001 | 2.8 (0.8) | 0.0004 | 0.8 (0.7) | 0.24 | 1.4 (0.8) | 0.08 | 0.09 (0.72) | 0.90 | 0.42 (0.80) | 0.60 |
LV end-diastolic volume | −1.9 (1.8) | 0.03 | −2.2 (1.9) | 0.24 | −7.1 (1.8) | <0.0001 | −4.0 (2.0) | 0.04 | −8.1 (1.83) | <0.0001 | −5.5 (2.0) | 0.006 |
Left atrial volume indexd | 1.9 (0.6) | 0.001 | 0.6 (0.6) | 0.34 | −1.6 (0.6) | 0.004 | −0.7 (0.6) | 0.28 | −1.6 (0.60) | 0.005 | −0.9 (0.63) | 0.15 |
LV systolic myocardial function | ||||||||||||
Absolute GLS | −0.93 (0.16) | <0.0001 | −0.58 (0.17) | 0.0005 | −0.59 (0.17) | 0.0005 | −0.42 (0.18) | 0.02 | −0.34 (0.17) | 0.04 | −0.27 (0.18) | 0.05 |
LV diastolic myocardial function | ||||||||||||
E/A ratio | −0.13 (0.02) | <0.0001 | −0.06 (.02) | 0.008 | −0.07 (0.02) | 0.003 | −0.03 (0.03) | 0.26 | −0.04 (0.02) | 0.14 | −0.008 (0.03) | 0.75 |
E/e’ ratio | 0.80 (0.15) | <0.0001 | 0.34 (.15) | 0.03 | 0.35 (0.15) | 0.004 | 0.35 (0.16) | 0.03 | 0.20 (0.15) | 0.20 | 0.16 (0.16) | 0.31 |
Lateral tissue Doppler e’ velocity | −0.77 (0.14) | <0.0001 | −0.34 (.14) | 0.02 | −0.32 (0.15) | 0.0004 | −0.36 (0.15) | 0.02 | −0.28 (0.15) | 0.05 | −0.22 (0.15) | 0.05 |
Hemodynamic variables | ||||||||||||
Cardiac output | .78 (.11) | <0.0001 | 0.41 (0.11) | 0.0002 | 0.27 (0.11) | 0.01 | 0.22 (0.11) | 0.06 | 0.12 (0.11) | 0.27 | 0.08 (0.11) | 0.47 |
Abbreviations: GLS, global longitudinal strain; HF, heart failure; BMI, body mass index; VAT, visceral adipose tissue; LV, left ventricle
NAFLD is defined as CT liver attenuation ≤ 40 HU
Base model: center, age, race, sex, education, income level, alcohol intake (drinks/week), smoking status (current/former vs. never), physical activity score
HF risk factors: systolic blood pressure, antihypertensive medication use, anti-hyperlipidemic medication use, total cholesterol, HDL cholesterol, diabetes status, GFR
Indexed to height2.7
Indexed to height